Afya revenue rises 6.1% to R$985 million
By Liezl GambeKey points
- Afya Limited (NASDAQ:AFYA; B3:A2FY34) reported third-quarter 2026 revenue of R$985.2 million, up 6.1% year over year, and net income of R$171 million, up 7.2%.
- Adjusted EBITDA increased 8.7% to R$433.8 million, with the quarterly margin improving 100 basis points to 44%.
- For the first nine months of 2026, revenue reached R$2.97 billion, adjusted EBITDA totaled R$1.35 billion, and free cash flow to equity reached R$629 million.
Afya Limited (NASDAQ:AFYA) reported third-quarter 2026 revenue of R$985.2 million, up 6.1% year over year, while net income increased 7.2% to R$171 million.
Adjusted EBITDA increased 8.7% to R$433.8 million, while its margin expanded to 44% from 43% in the third quarter of 2025.
Undergraduate education generated R$879.8 million in quarterly revenue, up 7.6%, while Continuing Education revenue declined 7.4% to R$64.9 million and Medical Practice Solutions revenue fell 2.7% to R$43 million.
For the first nine months of 2026, revenue increased 6.7% to R$2.97 billion, adjusted EBITDA rose 4.6% to R$1.35 billion, and net income reached R$634 million.
Operating cash flow reached R$1.33 billion, with a 99.5% cash conversion ratio, while cash and cash equivalents totaled R$1.29 billion and net debt declined R$169.7 million to R$1.20 billion.
Afya reaffirmed its 2026 revenue guidance of R$3.95 billion–R$4.10 billion and adjusted EBITDA forecast of R$1.70 billion–R$1.80 billion, while a proposed merger with Yduqs remains subject to shareholder and regulatory approvals.
